A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy

Iron deficiency anemia (IDA) is the most common form of anemia worldwide. Although oral iron is used as first-line treatment, many patients are unresponsive to or cannot take oral iron. This Phase III, open-label, non-inferiority study compared the efficacy and safety of ferumoxytol, a rapid, inject...

Descripción completa

Detalles Bibliográficos
Autores principales: Hetzel, David, Strauss, William, Bernard, Kristine, Li, Zhu, Urboniene, Audrone, Allen, Lee F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225478/
https://www.ncbi.nlm.nih.gov/pubmed/24639149
http://dx.doi.org/10.1002/ajh.23712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225478/
https://www.ncbi.nlm.nih.gov/pubmed/24639149
http://dx.doi.org/10.1002/ajh.23712

Ejemplares similares